Long-term Patency of Venous Stent After Sharp Recanalization for Benign Superior Vena Cava Occlusion.

In VivoJan 1, 2026

Ryosuke Shima, Masashi Fujimori, Takashi Yamanaka et al.

✦ AI-curated · Sources linked

Case in brief

A man in his 50s with short-bowel syndrome developed facial and upper-extremity edema from benign superior vena cava syndrome after repeated central venous catheter placement. Venography showed complete SVC occlusion (modified Stanford type 4). Under biplane fluoroscopy and cone-beam CT guidance, operators used a trans-septal needle for sharp recanalization and placed a 14 × 40 mm self-expanding bare-metal stent. Symptoms resolved the next day. In-stent restenosis at 10 months was treated with balloon dilatation; the stent then remained patent, with no recurrent SVCS, for 10 years of follow-up.

What made this case unusual

The report documents 10-year stent patency after sharp recanalization of a completely occluded benign SVC, following one re-intervention for restenosis.

Diagnostic / clinical pearl

In this case, image-guided sharp recanalization enabled stent placement despite complete benign SVC occlusion; restenosis was managed with balloon dilatation.

Source

Published in In Vivo. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Vascular Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.